Domain Alteration Chimeras Rewire Androgen Receptor Complexes

A November 11 peer-reviewed Nature paper introduces DALTACs, induced-proximity molecules designed to alter protein-complex topology without degrading either component. DALTAC-1 links androgen receptor and p300/CBP domains and produced preclinical prostate-tumor regressions.




